Phase 3 Postpartum Hemorrhage Clinical Trials
7 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–7 of 7 trials
Recruiting
Phase 3
EVE TRIAL , ALMA SYSTAM
Postpartum Haemorrhage (PPH)PPHPostpartum Hemorrhage (Primary)
ResQ Medical Ltd50 enrolled2 locationsNCT06646653
Recruiting
Phase 3
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
Postpartum Hemorrhage
Stony Brook University1,358 enrolled1 locationNCT05245227
Recruiting
Phase 3
Tranexamic Acid to Prevent Heavy Bleeding After Childbirth in Women At Higher Risk
Postpartum Hemorrhage
London School of Hygiene and Tropical Medicine30,000 enrolled1 locationNCT05562609
Recruiting
Phase 3
TRAnexamic Acid for Preventing Blood Loss Following a Cesarean Delivery in Women With Placenta pREVIA
Postpartum Hemorrhage
University Hospital, Bordeaux1,380 enrolled1 locationNCT04304625
Completed
Phase 3
studying the effect of different uterotonic agents in prevention of postpartum hemorrhage following cesarean section in high risk cases.
Postpartum hemorrhage following cesarean section
Sherine Hosny Mohamed240 enrolled1 locationACTRN12615000546550
Completed
Phase 3
The use of tranexamic acid to reduce blood loss during and after cesarean section
Prevention of Postpartum hemorrhage
Faculty of Medicine,Assiut University700 enrolled1 locationACTRN12612000313831
Active
Phase 3Phase 4
Comparison of the efficacy of oxtyocin agonist to oxytocin in the prevention of postpartum hemorrhage (PPH) in women undergoing vaginal delivery
vaginal delivery and blood lossPostpartum Hemorrhage
Dr Farouk720 enrolled1 locationACTRN12608000396325